Hennig H - Search Results

1

Infectivity of blood products containing cytomegalovirus DNA: results of a lookback study in nonimmunocompromised patients.

Ziemann M, Juhl D, Brockmann C, Görg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2017 Jul;57(7):1691-1698. doi: 10.1111/trf.14105. Epub 2017 Mar 28. Transfusion. 2017. PMID: 28370032

2

High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.

Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2007 Nov;47(11):1972-83. doi: 10.1111/j.1537-2995.2007.01420.x. Transfusion. 2007. PMID: 17958525

3

Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen.

Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Juhl D, et al. Among authors: hennig h. Transfusion. 2011 Jul;51(7):1477-85. doi: 10.1111/j.1537-2995.2010.03031.x. Epub 2011 Jan 28. Transfusion. 2011. PMID: 21276000

4

Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.

Ziemann M, Heuft HG, Frank K, Kraas S, Görg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2013 May;53(5):1088-94. doi: 10.1111/trf.12074. Epub 2013 Jan 16. Transfusion. 2013. PMID: 23320406

5

Seroprevalence and incidence of hepatitis E virus infection in German blood donors.

Juhl D, Baylis SA, Blümel J, Görg S, Hennig H. Juhl D, et al. Among authors: hennig h. Transfusion. 2014 Jan;54(1):49-56. doi: 10.1111/trf.12121. Epub 2013 Feb 26. Transfusion. 2014. PMID: 23441647

6

The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.

Ziemann M, Juhl D, Görg S, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfusion. 2013 Oct;53(10):2183-9. doi: 10.1111/trf.12199. Epub 2013 Apr 15. Transfusion. 2013. PMID: 23581526

7

Evaluation of potentially infectious blood donors in cases of presumed transfusion-transmitted cytomegalovirus infections.

Ziemann M, Hennig H. Ziemann M, et al. Among authors: hennig h. Biol Blood Marrow Transplant. 2014 Apr;20(4):593. doi: 10.1016/j.bbmt.2013.12.572. Epub 2014 Jan 3. Biol Blood Marrow Transplant. 2014. PMID: 24394803 Free article. No abstract available.

8

Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy?

Ziemann M, Hennig H. Ziemann M, et al. Among authors: hennig h. Transfus Med Hemother. 2014 Feb;41(1):40-4. doi: 10.1159/000357102. Epub 2013 Dec 19. Transfus Med Hemother. 2014. PMID: 24659946 Free PMC article. Review.

9

Parvovirus b19 infections and blood counts in blood donors.

Juhl D, Steppat D, Görg S, Hennig H. Juhl D, et al. Among authors: hennig h. Transfus Med Hemother. 2014 Feb;41(1):52-9. doi: 10.1159/000357650. Epub 2013 Dec 30. Transfus Med Hemother. 2014. PMID: 24659948 Free PMC article.

10

Cytomegalovirus Serostatus as Predictor for Adverse Events After Cardiac Surgery: A Prospective Observational Study.

Ziemann M, Heringlake M, Lenor P, Juhl D, Hanke T, Petersen M, Schön J, Heinze H, Groesdonk HV, Paarmann H, Hennig H. Ziemann M, et al. Among authors: hennig h. J Cardiothorac Vasc Anesth. 2017 Dec;31(6):2042-2048. doi: 10.1053/j.jvca.2016.10.024. Epub 2016 Oct 20. J Cardiothorac Vasc Anesth. 2017. PMID: 28073619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters